Literature DB >> 35602784

Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type.

Ryo Kawaura1, Masami Ohnishi1, Tomoya Hori1.   

Abstract

Extranodal NK/T cell lymphoma, nasal type (ENKL) primarily involves the nasal cavity. Although patients might visit an otorhinolaryngologist with nasal symptoms, such as nasal obstruction and epistaxis, it would be difficult to make a diagnosis correctly. We present a case of ENKL in which the patient had been in remission after initial treatment and relapsed 14 years after treatment. The patient had a worsening of nasal symptoms before the recurrence, but on this occasion, treatment such as sinusitis was successful in alleviating the symptoms. Although recurrence of lymphoma 10 years after treatment is rare, the possibility of recurrence should always be considered in post-malignant lymphoma cases as with any malignant tumor.
Copyright © 2022, Kawaura et al.

Entities:  

Keywords:  devic; enkl; extranodal nk/t cell lymphoma; nasal type; recurrence

Year:  2022        PMID: 35602784      PMCID: PMC9116688          DOI: 10.7759/cureus.24177

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  3 in total

1.  Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

Authors:  Motoko Yamaguchi; Yok-Lam Kwong; Won Seog Kim; Yoshinobu Maeda; Chizuko Hashimoto; Cheolwon Suh; Koji Izutsu; Fumihiro Ishida; Yasushi Isobe; Eisaburo Sueoka; Junji Suzumiya; Takao Kodama; Hiroshi Kimura; Rie Hyo; Shigeo Nakamura; Kazuo Oshimi; Ritsuro Suzuki
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

2.  P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833.

Authors:  M Egashira; N Kawamata; K Sugimoto; T Kaneko; K Oshimi
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

3.  Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.

Authors:  Liang Wang; Hua Wang; Jing-hua Wang; Zhong-jun Xia; Yue Lu; Hui-qiang Huang; Wen-qi Jiang; Yu-jing Zhang
Journal:  Oncotarget       Date:  2015-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.